Dr. Pandolfi presenting at CPhI in Madrid

What´s next for sterile contract manufacturing in emerging markets?

October 9, 2018Pharma Insight Briefings session at CPhI in Madrid

Fresenius Kabi operates a global network of more than 20 manufacturing sites worldwide focusing on sterile pharmaceuticals including in emerging markets such as Latin America and Asia. Manufacturing locally in specific countries becomes increasingly important not only for price considerations, but also due to governmental regulations and requirements for having access to the market. Here, we introduce two of our sites located in Indonesia and Brazil highlighting our capabilities to fill in vials and ampoules of IV drugs on a large commercial scale. The customized approach and flexibility provides the opportunity to offer tailored solutions for unique, specialized requirements. Once the development work is complete, we can formulate, fill/finish, label, and package our partners´ products according to their specifications.